OBSOLETE: Anomaly of chromosome 17

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:261748
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

The Orphanet entry 'Anomaly of chromosome 17' (Orphanet code 261748) is an obsolete classification that was previously used as a broad grouping term for chromosomal abnormalities involving chromosome 17. This entry has been retired from active use in the Orphanet classification system, meaning it no longer serves as a current diagnostic or reference category. Chromosome 17 abnormalities encompass a wide range of structural and numerical changes — including deletions, duplications, translocations, and other rearrangements — each of which has been reclassified into more specific disease entities with distinct clinical presentations. Examples of well-characterized conditions involving chromosome 17 include Smith-Magenis syndrome (17p11.2 deletion), Miller-Dieker lissencephaly syndrome (17p13.3 deletion), Charcot-Marie-Tooth disease type 1A (17p12 duplication), and Potocki-Lupski syndrome (17p11.2 duplication), among others. Because this is an obsolete umbrella term rather than a specific clinical entity, there are no defined symptoms, inheritance patterns, or treatments associated with this particular code. Patients and clinicians seeking information about a chromosome 17 abnormality should refer to the specific condition diagnosed through cytogenetic or molecular testing for accurate clinical guidance.

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Anomaly of chromosome 17.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Anomaly of chromosome 17 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Anomaly of chromosome 17 community →

No specialists are currently listed for OBSOLETE: Anomaly of chromosome 17.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Anomaly of chromosome 17.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Anomaly of chromosome 17Forum →

No community posts yet. Be the first to share your experience with OBSOLETE: Anomaly of chromosome 17.

Start the conversation →

Latest news about OBSOLETE: Anomaly of chromosome 17

No recent news articles for OBSOLETE: Anomaly of chromosome 17.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about OBSOLETE: Anomaly of chromosome 17

What is OBSOLETE: Anomaly of chromosome 17?

The Orphanet entry 'Anomaly of chromosome 17' (Orphanet code 261748) is an obsolete classification that was previously used as a broad grouping term for chromosomal abnormalities involving chromosome 17. This entry has been retired from active use in the Orphanet classification system, meaning it no longer serves as a current diagnostic or reference category. Chromosome 17 abnormalities encompass a wide range of structural and numerical changes — including deletions, duplications, translocations, and other rearrangements — each of which has been reclassified into more specific disease entities